Synopsis of recent research by authors named "Xin-Wen Yu"
- Xin-Wen Yu's research focuses predominantly on the development and evaluation of novel anti-cancer agents that inhibit the NF-κB signaling pathway, which is linked to chronic inflammation and hepatoma progression.
- Recent studies have highlighted the synthesis of various derivatives of 3,5-bis(arylidene)-4-piperidone and other compounds, demonstrating promising anti-hepatoma activity and low toxicity profiles against normal liver cells.
- Yu's work also encompasses evaluation of chemotherapy regimens in nasopharyngeal carcinoma, showcasing significant advancements in treatment approaches while assessing both efficacy and safety in clinical settings.
